Hematopoietic stem cell transplantation for pediatric autoimmune disease: Where we stand and where we need to go

Bone Marrow Transplantation

Volumn 44, Issue 3, 2009, Pages 137-143

  Krauss, A C ^a   Kamani, N R ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; THIOTEPA; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELIAC DISEASE; CLINICAL EFFECTIVENESS; CROHN DISEASE; FAMILIAL MEDITERRANEAN FEVER; GRAFT VERSUS HOST REACTION; HEMOLYTIC ANEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; IPEX SYNDROME; JUVENILE RHEUMATOID ARTHRITIS; NONHUMAN; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PULMONARY VASCULITIS; REGULATORY T LYMPHOCYTE; REVIEW; SAFETY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T CELL DEPLETION; TREATMENT INDICATION; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ANIMALS; AUTOIMMUNE DISEASES; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICE;

EID: 68949097506     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.147     Document Type: Review

References (78)

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369: 767-778.
2. Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: A multicenter cohort study. Arthritis Rheum 2003; 49: 501-507.
3. Ruperto N, Martini A. Network in pediatric rheumatology: The example of the Pediatric Rheumatology International Trials Organization. World J Pediatr 2008; 4: 186-191.
4. Wallace CA. Current management of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2006; 20: 279-300.
5. Tyndall A, Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 1996; 55 149-151.
6. Eedy DJ, Burrows D, Bridges JM, Jones FG. Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 1990; 300: 908.
7. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986; 1: 237-239.
8. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643-645.
9. Rabusin M, AndolinaM,Maximova N. Haematopoietic SCT in autoimmune diseases in children: Rationale and new perspectives. Bone Marrow Transplant 2008; 41(Suppl 2): S96-S99.
10. Baldwin JL, Storb R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977; 20: 1043-1048.
11. Meloni G, Capria S, Vignetti M, Mandelli F, Modena V. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: Regression of both diseases after autologous bone marrow transplantation. Blood 1997; 89: 4659.
12. Hinterberger W, Hinterberger-Fischer M, Marmont A. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753-759.
13. Burt RK, Verda L, Oyama Y, Statkute L, Slavin S. Nonmyeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immunopathol 2004; 26: 57-69.
14. Brinkman DM, de Kleer IM, ten Cate R, van Rossum MA, Bekkering WP, Fasth A et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: Long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007; 56: 2410-2421.
15. Gratwohl A, Passweg J, Gerber I, Tyndall A. Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Haematol 2001; 14 755-776.
16. Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621-3625.
17. Brinkman DM, Jol-van der Zijde CM, ten Dam MM, te Boekhorst PA, ten Cate R, Wulffraat NM et al. Resetting the adaptive immune system after autologous stem cell transplantation: Lessons from responses to vaccines. J Clin Immunol 2007; 27: 647-658.
18. Mellouli F, Ksouri H, Torjmen L, Abdelkefi A, Ladeb S, Ben Othman T et al. Transmission of type 1 diabetes by bone marrow transplantation: A case report. Pediatr Transplant 2009; 13: 119-122.
19. Marazuela M, Steegman JL. Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves' disease. Bone Marrow Transplant 2000; 26: 1217-1220.
20. Berisso GA, van Lint MT, Bacigalupo A, Marmont AM. Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease. Bone Marrow Transplant 1999; 23: 1091-1092.
21. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993; 341: 1243-1244.
22. Bargetzi MJ, Schonenberger A, Tichelli A, Fried R, Cathomas G, Signer E et al. Celiac disease transmitted by allogeneic non-T celldepleted bone marrow transplantation. Bone Marrow Transplant 1997; 20 607-609.
23. Ritchie DS, Sainani A, D'Souza A, Grigg AP. Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation. Am J Hematol 2005; 79: 299-302.
24. Wicker LS, Miller BJ, Chai A, Terada M, Mullen Y. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice. J Exp Med 1988; 167: 1801-1810.
25. Slavin S, Nagler A, Varadi G, Or R. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853-857.
26. Kojima R, Kami M, Kim SW, Murashige N, Kishi Y, Hori A et al. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 439-442.
27. Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 2008; 112: 3543-3553.
28. Alderuccio F, Chan J, Toh BH. Tweaking the immune system: Gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease. Autoimmunity 2008; 28 (e-pub ahead of print).
29. Alderuccio F, Siatskas C, Chan J, Field J, Murphy K, Nasa Z et al. Haematopoietic stem cell gene therapy to treat autoimmune disease. Curr Stem Cell Res Ther 2006; 1: 279-287.
30. de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006; 107: 1696-1702.
31. van Bekkum DW. Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases. J Leukoc Biol 2002; 72: 609-620.
32. Morton JI, Siegel BV. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA 1974; 71: 2162-2165.
33. Morton JI, Siegel BV. Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation. Transplantation 1979; 27: 133-134.
34. Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992; 148: 1693-1698.
35. van Gelder M, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995; 16: 343-351.
36. Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Oo MM et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985; 82: 2483-2487.
37. Ikehara S, Kawamura M, Takao F, Inaba M, Yasumizu R, Than S et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87 8341-8344.
38. Ikehara S, Ohtsuki H, Good RA, Asamoto H, Nakamura T, Sekita K et al. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci USA 1985; 82 7743-7747.
39. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435: 620-627.
40. Ikehara S. Stem cell transplantation for autoimmune diseases: What can we learn from experimental models? Autoimmunity 2008; 28 (e-pub ahead of print).
41. Ikehara S. Intra-bone marrow-bone marrow transplantation: A new strategy for treatment of stem cell disorders. Ann NY Acad Sci 2005; 1051: 626-634.
42. Chan J, Ban EJ, Chun KH, Wang S, Backstrom BT, Bernard CC et al. Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol 2008; 181: 7571-7580.
43. De Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: Analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63: 1318-1326.
44. Ferreira RA, Vastert SJ, Abinun M, Foster HE, Modesto C, Olive T et al. Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis. Bone Marrow Transplant 2006; 38 249-251.
45. Wulffraat NM, Brinkman D, Ferster A, Opperman J, ten Cate R, Wedderburn L et al. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplant 2003; 32(Suppl 1): S61-S64.
46. Wulffraat NM, Sanders LA, Kuis W. Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2000; 2: 316-323.
47. Kishimoto T, Hamazaki T, Yasui M, Sasabe M, Okamura T, Sakata N et al. Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis. Int J Hematol 2003; 78: 453-456.
48. Chen J, Wang Y, Kunkel G, Zhao H, Xue H, Xie X et al. Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus. Clin Rheumatol 2005; 24: 464-468.
49. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35: 869-879.
50. Marmont AM, Gualandi F, Occhini D, Morandi F, Ferretti E, Pezzolo A et al. Catastrophic relapse of Evans syndrome five years after allogeneic BMT not with standing full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity 2006; 39: 505-511.
51. Urban C, Lackner H, Sovinz P, Benesch M, Schwinger W, Dornbusch HJ et al. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation. Eur J Haematol 2006; 76 526-530.
52. Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005; 128: 552-563.
53. Kline RM, Neudorf SM, Baron HI. Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia. Pediatrics 2007; 120: E1120-e1122.
54. Elhasid R, Rowe JM, Berkowitz D, Ben-Arush M, Bar-Shalom R, Brik R. Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant 2004; 33: 1257-1259.
55. Jones OY, Cahill RA. Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis. Immunol Res 2008; 41: 26-33.
56. Rao A, Kamani N, Filipovich A, Lee SM, Davies SM, Dalal J et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 2007; 109: 383-385.
57. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-149.
58. Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 2001; 13: 533-538.
59. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-21.
60. Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344: 1758-1762.
61. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15: 430-435.
62. Mazzolari E, Forino C, Fontana M, D'Ippolito C, Lanfranchi A, Gambineri E et al. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant 2005; 35: 1033-1034.
63. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39: 537-545.
64. Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13: 168-176.
65. Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE et al. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2008; 67: 98-104.
66. Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G et al. Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 2004; 125: 749-755.
67. Milledge J, Shaw PJ, Mansour A, Williamson S, Bennetts B, Roscioli T et al. Allogeneic bone marrow transplantation: Cure for familial Mediterranean fever. Blood 2002; 100: 774-777.
68. De Stefano P, Zecca M, Giorgiani G, Perotti C, Giraldi E, Locatelli F. Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft. Br J Haematol 1999; 106: 1063-1064.
69. Gassas A, Sung L, Saunders EF, Doyle JJ. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens. Bone Marrow Transplant 2006; 38: 739-743.
70. Dvorak CC, Agarwal R, Dahl GV, Gregory JJ, Feusner JH. Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia. Biol Blood Marrow Transplant 2008; 14: 824-830.
71. MacMillan ML, Davies SM, Nelson GO, Chitphakdithai P, Confer DL, King RJ et al. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 2008; 14(9 Suppl): 16-22.
72. Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schonberger S et al. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biol Blood Marrow Transplant 2007; 13: 1338-1345.
73. Ilowite NT. Update on biologics in juvenile idiopathic arthritis. Curr Opin Rheumatol 2008; 20: 613-618.
74. Lepore L, Kiren V. Autologous bone marrow transplantation versus alternative drugs in pediatric rheumatic diseases. Haematologica 2000; 85(11 Suppl): 89-92.
75. Petty RE. Prognosis in children with rheumatic disease; justification for consideration of new therapies. Rheumatology (Oxford) 1999; 38: 739-742.
76. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol 2000; 27: 1884-1891.
77. Moss KE, Isenberg DA. Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 2001; 40: 863-867.
78. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A et al. Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006; 54: 3971-3978.